05:26

How to interpret ROC curves

04:38

4:More Background Information on Populations and Samples

06:44

3: Types of Variables and Scales of Measurement

09:34

2: Dealing with missing data

07:46

1: Overview of Data Analysis & Cleaning Your Datafile

07:15

Blinding in Clinical Trials

00:55

Tutorial on making an interactive video in YouTube

03:45

How to calculate patient-specific estimates of effect from a study

07:33

Effect Modification

04:47

Part 2 Association between risk factors and shingles BMJ 2014

07:25

Part 1: Critical appraisal of risk factors for shingles study BMJ 2014

10:43

Introduction to Personal Learning Networks & Using Twitter to Cultivate Them

01:36

Welcome to Evidence Based Medicine

04:31

Interpreting a Subgroup Analysis: Is There a Real Effect?

07:25

Evaluating a Subgroup Analysis: Was the Data Analyzed Properly?

06:37

Evaluating a Subgroup Analysis: Was it Designed Properly?

05:52

Overview of Subgroup Analysis

05:05

How To Calculate Patient Specific Number Needed To Treat

04:26

Concealed Allocation: What Is It and Why Is It Important?

06:57

Propensity Scores 101

41:23

Review of the 2013 ACC/AHA Cholesterol Guidelines

02:47

What Is Length Time Bias?

02:47

What Is Lead Time Bias?

06:31

Limitations of Clinical Practice Guidelines

06:47

Overview of Clinical Practice Guidelines

10:09

Principles of Screening

01:55

Levels of Prevention

05:00

Fixed Effects and Random Effects Models

05:01

Interpreting Hazard Ratios

05:47

Summary Measures Used in Systematic Reviews

08:54

What is Heterogeneity?

05:33

How to Interpret a Forest Plot

07:28

Publication Bias

04:57

How to Critically Appraise a Systematic Review: Part 2

07:42

How to Critically Appraise a Systematic Review: Part 1

04:33

Overview of Review Articles

03:48

How To Calculate The Number Needed To Treat

05:20

P-values and Type I Error

04:16

Determining Causality: A Review of the Bradford Hill Criteria

11:00

How to Interpret and Use a Relative Risk and an Odds Ratio

06:24

Controlling Confounding During the Design Phase of a Study

07:12

How to Critically Appraise a Harm Study- Part 2

05:42

How to Critically Appraise a Harm Study- Part 1

06:08

Residual Confounding in Observational Studies

03:11

How to Calculate Relative Risk Reduction

10:27

How to Read and Use the JAMA Rational Clinical Exam Series

05:58

How reliable is a physical exam maneuver?

04:53

Case-Control Studies: A Brief Overview

05:34

Cohort Studies: A Brief Overview

03:31

Relative Risk Reduction Can Be Relatively Misleading

08:44

Composite Endpoints: Useful But Sometimes Misleading

05:28

Power, Type II error, and Sample Size

05:03

Why Randomization Is Important

01:23

Prognosis clinical scenario resolution

04:44

Intention-to-treat analysis: What is it and why is it important?

09:39

How to Critically Appraise a Therapy Study- Part 2

09:09

How to Critically Appraise a Therapy Study- Part 1

01:29

Prognosis Scenario Introduction

09:19

How to Interpret the Results of Prognostic Studies

11:02

Statistics Corner: Overview of Regression Analysis